6-Thioguanine treatment of uncontrolled thrombocytosis in polycythemia vera and essential thrombocythemia
Delfini, C.; Porcellini, A.; Izzi, T.; Baronciani, D.
Haematologica 69(6): 766-767
1984
ISSN/ISBN: 0390-6078 PMID: 6441754 Document Number: 222036
Document emailed within 1 workday
Related Documents
Murphy, S.; Peterson, P.; Iland, H.; Laszlo, J. 1997: Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment Seminars in Hematology 34(1): 29-39Fruchtman, S.M.; Mack, K.; Kaplan, M.E.; Peterson, P.; Berk, P.D.; Wasserman, L.R. 1997: From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera Seminars in Hematology 34(1): 17-23
Brandt, L.; Anderson, H. 1995: Peroral 32P in polycythemia vera and essential thrombocytopenia. An old method still of current interest Lakartidningen 92(34): 2989-2992
Meytes, D.; Shacked, N.; Padeh, B.; Czerniak, P.; Pinkhas, J.; Ramot, B. 1972: Immunoglobulin levels in polycythemia vera, erythrocytosis, secondary polycythemia and myelofibrosis Israel Journal of Medical Sciences 8(7): 925-931
Parmentier, C.; Gardet, P. 1994: The use of 32 phosphorus (32P) in the treatment of polycythemia vera Nouvelle Revue Francaise d'Hematologie 36(2): 189-192
Komatsu, N. 2012: Pathogenesis and treatment of polycythemia vera Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 314-320
Tesselaar, M.E.; Wijermans, P.W.; Metsaars, J.A.; Gerrits, W.B.; Haak, H.L. 1996: Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera Nederlands Tijdschrift Voor Geneeskunde 140(38): 1900-1902
Andreasson, B.ör.; Johansson, P.; Samuelsson, J. 2009: Essential thrombocytosis--a criteria diagnosis. Important to differentiate from reactive/secondary thrombocytosis Lakartidningen 106(3): 110-113
Neustroev, G.V. 1985: Physiological methods of treatment of patients with polycythemia vera Terapevticheskii Arkhiv 57(7): 54-59
Krasiukova, L.I.; Sedova, G.T. 1983: Experience in the ambulatory observation and treatment of patients with polycythemia vera Gematologiia i Transfuziologiia 28(11): 29-30
Sánchez Fayos, J.; Román Barbero, A.; Nevado Reviriego, I. 1997: Efficacious treatment of a fatal blood disease: polycythemia vera Sangre 42(3): 215-218
Osechenskaia, G.V.; Krasiukova, L.I. 1978: Current aspects of the treatment of polycythemia vera under polyclinical conditions Problemy Gematologii i Perelivaniia Krovi 23(1): 21-24
Altenbrunn, H.J.; Stober, D.; Miersch, G. 1971: Radiophosphorus treatment of polycythemia vera, our experiences after 142 treatments of 53 patients Das Deutsche Gesundheitswesen 26(10): 429-432
Hochhaus, A.; Mindner, K.; Ostermann, G.; Höche, D. 1990: Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis Folia Haematologica 117(6): 765-770
Najean, Y. 1992: Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies Presse Medicale 21(37): 1753-1757
Delage, R.; Demers, C.; Cantin, G.; Roy, J. 1996: Treatment of essential thrombocythemia during pregnancy with interferon-alpha Obstetrics and Gynecology 87(5 Pt 2): 814-817
Kornblihtt, L.I.; Vassallu, P.S.; Heller, P.; Molinas, F.C. 2002: Treatment of essential thrombocythemia with anagrelide: a ten-year experience Medicina 62(3): 231-236
Dyk, T.; Piotrowski, M.; Kostecka, W. 1973: Acute hemopericardium due to acute thrombocytopenia developing during Busulphan treatment of polycythemia vera Polski Tygodnik Lekarski 28(7): 259-260
Rorvik, T.O. 1974: Polycythemia vera Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(32): 2260-2263
Reed, C.; Ling, G.V.; Gould, D.; Kaneko, J.J. 1970: Polycythemia vera in a cat Journal of the American Veterinary Medical Association 157(1): 85-91